We chose the diabetogenic auto-antigen IGRP because, in spite of its pharmaceutical relevance as being directly associated with the development of type 1 diabetes, to the best of our knowledge there is no example in the literature showing a significant level of expression of this protein. This evidence concerns the gene G6PC2 and type 1 diabetes mellitus.